South and Central America Low Molecular Weight Heparin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine, Nadroparin, and Others), Packaging (Multi-Vials and Prefilled Syringes), Application [Deep Vein Thrombosis, Acute Coronary Syndrome (ACS), Pulmonary Embolism, and Others], and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

Name: South and Central America Low Molecular Weight Heparin Market
SKU: Healthcare IT
Rating: 4.9 (13 reviews)

The low molecular weight heparin market in South and Central America is expected to grow from US$ 202.69 million in 2021 to US$ 303.39 million by 2028; it is estimated to grow at a CAGR of 5.9% from 2021 to 2028.

Low molecular weight heparins (LMWH) can be subcutaneously administered once a day without the need for any supervision. However, the effects of unfractionated heparin (UFH) or standard heparin vary from patient to patient. Therefore, it can only be administered to hospitalized patients under supervision. In addition, the LMWH has more predictable pharmacokinetic properties compared to unfractionated heparin, which allows its administration in fixed doses based on laboratory monitoring, without the need for dose adjustments. The low molecular weight fractions of heparin have the molecular weight of ~3,500–8,000 Daltons, while unfractionated heparin has a molecular weight of 15,000 Daltons; thus, the former react less with platelets than the latter. Moreover, the LMWH is less likely to induce immune allergic thrombocytopenia, which is a severe side effect of unfractionated heparin (UFH). This condition is often complicated by arterial thrombosis. In addition, properties such as better bioavailability, predictable dose-response, and longer plasma half-life than unfractionated heparin make low molecular weight heparin a preferred choice for anticoagulation therapy. Such advantages of the LMWH over unfractionated heparin are boosting its demand, thereby spurring market growth, which is further anticipated to drive the market in South and Central America.

Countries in South and Central America are famous for medical tourism, but they have seen adverse effects of the COVID-19 pandemic in the past two years. After the onset of the second wave of the COVID-19 outbreak, there were 5,395,044 new cases in Argentina. Thus, the region was on the verge of imposing the second lockdown in 2021. In 2020, the market stakeholders lost their businesses due to the shutdown of their businesses for indefinite periods. SARS-2-CoV can contribute to VTE or arterial disease due to increased inflammatory response, hypoxia, immobilization, and DIC. The risk of developing VTE is higher in critically ill COVID-19 patients. In addition to hemostatic changes, immobility, systemic inflammatory status, mechanical ventilation, and central catheters increase the risk of thromboembolism, while diet-related and hepatic changes alter the production of coagulation factors. Identified risk factors for VTE include hospitalization in the intensive care unit, and higher white blood cell count, neutrophil/lymphocyte ratio, and D-dimer value. The COVID-19 pandemic can affect the prevention and treatment of thrombotic or thromboembolic diseases in different ways. The protocols for thromboprophylaxis, anticoagulation, and additional considerations for the management of coagulation disorders and the bleeding should be implemented in each facility by the most current recommendations in the region.

South and Central America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

South and Central America Low Molecular Weight Heparin Market Segmentation

South and Central America Low Molecular Weight Heparin Market – By Product Type

South and Central America Low Molecular Weight Heparin Market – By Packaging

Multi-Vials
Prefilled Syringes

South and Central America Low Molecular Weight Heparin Market – By Application

Deep Vein Thrombosis
Acute Coronary Syndrome (ACS)
Pulmonary Embolism
Others

South and Central America Low Molecular Weight Heparin Market – By End User

Hospitals
Clinics
Ambulatory Surgical Centers
Others

South and Central America Low Molecular Weight Heparin Market– By Country

Brazil
Argentina
Rest of South and Central America

South and Central America Low Molecular Weight Heparin Market-Companies Mentioned

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 SCAM Low Molecular Weight Heparin Market – By Product Type

1.3.2 SCAM Low Molecular Weight Heparin Market – By Packaging

1.3.3 SCAM Low Molecular Weight Heparin Market – By Application

1.3.4 SCAM Low Molecular Weight Heparin Market – By End User

1.3.5 SCAM Low Molecular Weight Heparin Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. SCAM Low Molecular Weight Heparin Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 SCAM PEST Analysis

4.3 Experts Opinion

5. SCAM Low Molecular Weight Heparin Market– Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Future Trends

5.4 Impact Analysis

6. Low Molecular Weight Heparin Market– SCAM Analysis

6.1 SCAM Low Molecular Weight Heparin Market Revenue Forecast and Analysis

7. SCAM Low Molecular Weight Heparin Market– By Product Type

7.1 Overview

7.2 SCAM Low Molecular Weight Heparin Market, By Product Type, 2021 & 2028 (%)

7.3 Enoxaparin

7.3.1 Overview

7.3.2 Enoxaparin: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.4 Dalteparin

7.4.1 Overview

7.4.2 Dalteparin: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.5 Nadroparin

7.5.1 Overview

7.5.2 Nadroparin: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.6 Fraxiparine

7.6.1 Overview

7.6.2 Fraxiparine: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.7 Tinzaparin

7.7.1 Overview

7.7.2 Tinzaparin: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

8. SCAM Low Molecular Weight Heparin Market– By Packaging

8.1 Overview

8.2 SCAM Low Molecular Weight Heparin Market Share by Packaging - 2021 & 2028 (%)

8.3 Multi-Vials

8.3.1 Overview

8.3.2 Multi-Vials: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

8.4 Prefilled Syringes

8.4.1 Overview

8.4.2 Prefilled Syringes: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

9. SCAM Low Molecular Weight Heparin Market– By Application

9.1 Overview

9.2 SCAM Low Molecular Weight Heparin Market, By Application, 2021 & 2028 (%)

9.3 Deep Vein Thrombosis

9.3.1 Overview

9.3.2 Deep Vein Thrombosis: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

9.4 Acute Coronary Syndrome (ACS)

9.4.1 Overview

9.4.2 Acute Coronary Syndrome (ACS): SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

9.5 Pulmonary Embolism

9.5.1 Overview

9.5.2 Pulmonary Embolism: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

10. SCAM Low Molecular Weight Heparin Market– By End User

10.1 Overview

10.2 SCAM Low Molecular Weight Heparin Market, By End User, 2021 & 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

10.4 Clinics

10.4.1 Overview

10.4.2 Clinics: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

10.5 Ambulatory Surgical Centers

10.5.1 Overview

10.5.2 Ambulatory Surgical Centers: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

11. SCAM Low Molecular Weight Heparin Market – Country Analysis

11.1 SCAM: Low Molecular Weight Heparin Market

11.1.1 Overview

11.1.2 SCAM: Low Molecular Weight Heparin Market Share by Country – 2021 & 2028, (%)

11.1.2.1 Brazil: Low Molecular Weight Heparin Market- Revenue and Forecast to 2028 (USD Million)

11.1.2.1.1 Brazil: Low Molecular Weight Heparin Market- Revenue and Forecast to 2028 (USD Million)

11.1.2.1.2 Brazil Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.3 Brazil Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.4 Brazil Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.5 Brazil Low Molecular Weight Heparin Market, By End User – Revenue and Forecast to 2028 (USD Million)

11.1.2.2 Argentina: Low Molecular Weight Heparin Market- Revenue and Forecast to 2028 (USD Million)

11.1.2.2.1 Argentina: Low Molecular Weight Heparin Market- Revenue and Forecast to 2028 (USD Million)

11.1.2.2.2 Argentina Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.3 Argentina Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.4 Argentina Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.5 Argentina Low Molecular Weight Heparin Market, By End User – Revenue and Forecast to 2028 (USD Million)

11.1.2.3 Rest of SCAM: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (USD Million)

11.1.2.3.1 Rest of SCAM: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (USD Million)

11.1.2.3.2 Rest of SCAM Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.3 Rest of SCAM Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.4 Rest of SCAM Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.5 Rest of SCAM Low Molecular Weight Heparin Market, By End User – Revenue and Forecast to 2028 (USD Million)

12. Impact of COVID-19 Pandemic on SCAM Low Molecular Weight Heparin Market

12.1 SCAM: Impact Assessment of COVID-19 Pandemic

13. SCAM Low Molecular Weight Heparin Market–Industry Landscape

13.1 Overview

13.2 Organic Developments

13.2.1 Overview

13.3 Inorganic Developments

13.3.1 Overview

14. Company Profiles

14.1 TEVA PHARMACEUTICAL INDUSTRIES LTD

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Abbott

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Novartis

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Sanofi

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Pfizer Inc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 B. Braun Medical Inc.

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Dr. Reddy's Laboratories

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 LEO Pharma A/S

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Aspen Holdings

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. SCAM Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)

Table 2. Brazil Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 3. Brazil Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)

Table 4. Brazil Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 5. Brazil Low Molecular Weight Heparin Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 6. Argentina Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 7. Argentina Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)

Table 8. Argentina Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 9. Argentina Low Molecular Weight Heparin Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 10. Rest of SCAM Low Molecular Weight Heparin Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 11. Rest of SCAM Low Molecular Weight Heparin Market, By Packaging – Revenue and Forecast to 2028 (USD Million)

Table 12. Rest of SCAM Low Molecular Weight Heparin Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 13. Rest of SCAM Low Molecular Weight Heparin Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 14. Organic Developments in the SCAM Low Molecular Weight Heparin Market

Table 15. Inorganic Developments in the SCAM Low Molecular Weight Heparin Market

Table 16. Glossary of Terms, SCAM Low Molecular Wight Heparin Market

LIST OF FIGURES

Figure 1. SCAM Low Molecular Weight Heparin Market Segmentation

Figure 2. SCAM Low Molecular Weight Heparin Market, By Country

Figure 3. SCAM Low Molecular Weight Heparin Market Overview

Figure 4. Enoxaparin Segment Held Largest Share of Product Type Segment in SCAM Low Molecular Weight Heparin Market

Figure 5. Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. SCAM: PEST Analysis

Figure 7. Experts Opinion

Figure 8. SCAM Low Molecular Weight Heparin Market Impact Analysis of Driver and Restraints

Figure 9. SCAM Low Molecular Weight Heparin Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10. SCAM Low Molecular Weight Heparin Market, By Product Type, 2021 & 2028 (%)

Figure 11. Enoxaparin: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 12. Dalteparin: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. Nadroparin: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. Fraxiparine: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 15. Tinzaparin: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 16. Others: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 17. SCAM LMWH Market Share by Packaging - 2021 & 2028 (%)

Figure 18. Multi-Vials: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 19. Prefilled Syringes: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 20. SCAM Low Molecular Weight Heparin Market, By Application, 2021 & 2028 (%)

Figure 21. Deep Vein Thrombosis: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 22. Acute Coronary Syndrome (ACS): SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 23. Pulmonary Embolism: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 24. Others: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. SCAM Low Molecular Weight Heparin Market, By End User, 2021 & 2028 (%)

Figure 26. Hospitals: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 27. Clinics: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 28. Ambulatory Surgical Centers: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 29. Others: SCAM Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 30. SCAM: Low Molecular Weight Heparin Market, By Key Country – Revenue (2021) (USD Million)

Figure 31. SCAM: Low Molecular Weight Heparin Market Share by Country – 2021 & 2028, (%)

Figure 32. Brazil: Low Molecular Weight Heparin Market- Revenue and Forecast to 2028 (USD Million)

Figure 33. Argentina: Low Molecular Weight Heparin Market- Revenue and Forecast to 2028 (USD Million)

Figure 34. Rest of SCAM: Low Molecular Weight Heparin Market - Revenue and Forecast to 2028 (USD Million)

Figure 35. Impact Of COVID-19 Pandemic in SCAM Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America Low Molecular Weight Heparin Market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South and Central America Low Molecular Weight Heparin Market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South and Central America market trends and outlook coupled with the factors driving the Low Molecular Weight Heparin Market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
South America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
South and Central America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission,..	May 2022
South and Central America In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syring..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000